tricalcium phosphate has been researched along with (3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Atsuta, I; Ayukawa, Y; Jinno, Y; Koyano, K; Ogino, Y; Tsukiyama, Y | 1 |
1 other study(ies) available for tricalcium phosphate and (3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid
| Article | Year |
|---|---|
Vertical bone augmentation with fluvastatin in an injectable delivery system: a rat study.
Topics: Animals; Biocompatible Materials; Bone Density; Calcium Phosphates; Collagen; Drug Carriers; Drug Delivery Systems; Fatty Acids, Monounsaturated; Female; Fluvastatin; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Osteogenesis; Rats; Rats, Wistar; Skull | 2009 |